Antibodies

Overview

Antibodies are an essential component of the immune system, capable of recognizing and neutralizing harmful pathogens like viruses and bacteria. They are proteins produced by immune cells known as B-cells in response to the presence of foreign substances or antigens. These antigens trigger the immune system to identify and initiate the production of specific antibodies that can bind to them and help to remove them from the body. Antibodies are crucial in human health research as they play a significant role in the development of therapies for infectious diseases and autoimmune disorders. Scientists can use antibodies to identify and isolate specific disease-causing pathogens and study their biological properties, leading to the development of accurate diagnostic tests and effective vaccine programs. Moreover, researchers are also studying the role of antibodies in the fight against cancer. Certain antibodies can target and kill cancerous cells by triggering an immune response, leading to the development of new cancer treatment approaches. In addition to their role in research, antibodies are used in clinical settings to treat a broad range of diseases. Some antibody-based therapies work by blocking the action of harmful antibodies that contribute to autoimmune disorders or replacing antibodies that are deficient in patients with certain diseases. In conclusion, antibodies play a critical role in human health research by providing insights into the immune system's function and aiding in the development of diagnostic tests, and treatments for a wide range of diseases. Investing in research into antibodies will have significant benefits for human health in the long term.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 29 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Effect of vitamin D status on a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) and interleukin 6 in patients with acute myeloid leukaemia
  Dina Ashraf Abdelhady et al. · 2025 · European Journal of Medical Research
• Effect of vitamin D status on a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) and interleukin 6 in patients with acute myeloid leukaemia
  2025 · European journal of medical research
• Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
  2023 · Frontiers in Immunology
• Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
  R. Bailén et al. · 2023 · Frontiers in Immunology
• Dopamine D2 and Serotonin 5-HT1A Dimeric Receptor-Binding Monomeric Antibody scFv as a Potential Ligand for Carrying Drugs Targeting Selected Areas of the Brain
  2022 · Biomolecules
• CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons
  2022 · JCI Insight
• Dopamine D2 and Serotonin 5-HT1A Dimeric Receptor-Binding Monomeric Antibody scFv as a Potential Ligand for Carrying Drugs Targeting Selected Areas of the Brain
  Agata Kowalik et al. · 2022 · Biomolecules
• CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons
  2022 · JCI Insight

A sample of recent works citing this journal's research on Antibodies, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics